Cardiologia Italiana del Territorio

ippocrate56

/Calogero Calcullo

About Calogero Calcullo

This author has not yet filled in any details.
So far Calogero Calcullo has created 28 blog entries.
- 04/2016

Clinical Diagnosis of Electrical vs Anatomic Left Ventricular Hypertrophy

aprile 2016|News, Novità’ dalla letteratura|0 Comments

Most physician readers of Aro’s and Chugh’s elegant review of electrical and anatomic types of LVH and the implications will be puzzled by the concepts that electrical LVH (ECG/LVH) and anatomic LVH (echo/LVH and MRI/LVH) might be different entities, and that patients may have one form without the other. These concepts have been evolving over

- 04/2016

Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure

aprile 2016|Cardiologia: presente e futuro... Discutiamone, News, Novità’ dalla letteratura|0 Comments

Patients with heart failure have a poor prognosis, yet outcomes might be improved by early identification of risk. Proenkephalin (proENK), a novel biomarker, is a stable surrogate marker for endogenous enkephalins and is an independent predictor of heart failure and death in patients who had an acute myocardial infarction. This is the first study to

- 03/2016

UN CUORE CHE CRESCE

marzo 2016|Archivio Eventi patrocinati da ANCE|0 Comments

23 - 25 Marzo 2016 Villa Barile Caltanissetta   vedi dettagli  

- 03/2016

Role of Vorapaxar After Coronary Revascularization

marzo 2016|News|0 Comments

We aim to evaluate the potential benefit and risk of addition of vorapaxar to standard medical therapy in patients who underwent coronary revascularization with either percutaneous coronary revascularization or coronary artery bypass graft surgery. We searched PubMed, EMBASE, the Cochrane Central Register of Controlled trials, and the clinical trial registry maintained at clinicaltrials.gov for randomized

- 03/2016

Parere positivo Fda all’antiaggregante vorapaxar dopo un infarto del miocardio.

marzo 2016|News, Novità’ dalla letteratura|0 Comments

Dopo l’endorsement dei giorni scorsi ricevuto dello staff interno dell’Fda, lo scorso 15 gennaio il nuovo antiaggregante orale vorapaxar ha ricevuto il parere positivo  degli esperti del Cardiovascular and Renal Drugs Advisory Committee dell’Fda. Con 10 voti a 1, gli esperti ne hanno raccomandato l’approvazione come terapia antiaggregante aggiuntiva a quella standard (ASA o ASA

- 02/2016

Long-Term Outcome of Incomplete Revascularization After PCI

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Objectives  The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete revascularization (IR) with death, repeat revascularization, and myocardial infarction (MI) in a large nationwide registry. Background  The benefits of multivessel PCI are controversial.

- 02/2016

Allopurinol and Cardiovascular Outcomes in Adults With Hypertension

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Allopurinol lowers blood pressure in adolescents and has other vasoprotective effects. Whether similar benefits occur in older individuals remains unclear. We hypothesized that allopurinol is associated with improved cardiovascular outcomes in older adults with hypertension. Data from the United Kingdom Clinical Research Practice Datalink were used. Multivariate Cox-proportional hazard models were applied to estimate hazard

- 02/2016

Convention Consensus Document Intersocietaria

febbraio 2016|News, Novità’ dalla letteratura, Senza categoria|0 Comments

Si è concluso Giovedì 4 Febbraio il “Convention Consensus Document Intersocietaria”, tenutosi a Catania su iniziativa dell’A.N.M.C.O., che ha visto riunite le più importanti società scientifiche di area medica, di farmacologia, di biochimica clinica e di biologia molecolare clinica, per condividere la realizzazione del primo Documento Scientifico di Consenso Intersocietario Pluridisciplinare sulle dislipidemie. Con il

- 02/2016

Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

Background  Diagnosed diabetes mellitus (DM) is a consistently documented risk factor for ischemic stroke in patients with atrial fibrillation (AF). Objectives  The purpose of this study was to assess the association between duration of diabetes and elevated hemoglobin A1c (HbA1c) with risk of stroke among diabetic patients with AF. Methods  We assessed this association in the ATRIA

- 02/2016

Meta-Analysis of Risks for Short-Term Readmission in Patients With Heart Failure

febbraio 2016|News, Novità’ dalla letteratura|0 Comments

This investigation sought to quantify the risk factors for short-term readmission in patients with heart failure (HF). Electronic databases were systematically searched for studies reporting relative risk, odds ratio, and hazard ratio for the combined primary outcome of all-cause hospital readmission or all-cause mortality ≤90 days from discharge of patients with HF. Clinical characteristics, study design,